-

Shareholder Alert: Robbins LLP Announces K12 Inc. (LRN) is Being Sued for Misleading Shareholders

SAN DIEGO & HERDON, Va.--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that a purchaser of K12 Inc. (NYSE:LRN) filed a class action complaint against the Company and its officers and directors for alleged violations of the Securities & Exchange Act of 1934 between April 27, 2020 and September 18, 2020. K12 is a technology-based education company that provides online content and educational services worldwide.

If you suffered a loss due to K12's misconduct, click here.

K12 Inc. (LRN) Misled Shareholders About its Ability to Support Online Learning During the Pandemic

According to the complaint, following the nationwide closure of schools due to COVID-19, K12 and its officers and directors disseminated false and misleading statements touting the viability of the Company's online platforms, cybersecurity protocols, preparedness for large volumes of students, and its ability to support and train students, parents, and teachers. Based on these misstatements, the price of K12 shares rose to an all-time high of $51.60 on August 5, 2020. In reality, however, K12 did not have the technological capabilities to support and service the massive increase in traffic on its website and learning platforms. When news of K12's deficiencies were revealed, the price of its stock began to decline. The stock fell 7% on August 27, 2020, when Miami-Dade County teachers reported K12's training was ineffective and "unacceptable." The stock fell over 10.5% again on September 3, after Miami-Dade County experienced significant technical difficulties and revealed that the superintendent never signed the $15.3 billion contract with K12. Then, on September 10, the stock fell another 11.5% after the Miami-Dade County Public School Board voted to terminate its K12 contract. Finally, Beaufort County School District also terminated its contact with K12, causing the stock to decline nearly 5% on September 18, 2020. The stock has yet to recover.

If you purchased K12 Inc. (LRN) securities between April 27, 2020 and September 18, 2020, you have until January 19, 2021, to ask the court to appoint you lead plaintiff for the class.

Contact us to learn more:
Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against K12 Inc. settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Regencell Bioscience Holdings Limited Class Action Reminder - Robbins LLP Encourages RGC Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Regencell Bioscience Holdings Limited (NASDAQ: RGC) securities between October 28, 2024 and October 31, 2025. Regencell is a purported early-stage bioscience company focused on the research, development, and commercialization of traditional Chinese medicine (“TCM”) for the treatment of attention-deficit/hyperactivity disorder (“ADHD”) and autis...

POET Technologies Inc. Class Action Reminder - Robbins LLP Encourages POET Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired POET Technologies Inc. (NASDAQ: POET) securities between April 1, 2026 and 8:57 A.M. ET on April 27, 2026. POET Technologies describes itself as a "design and development company offering photonic integrated packaging solutions based on the POET Optical Interposer™, a novel platform that allows the seamless integration of electronic and photoni...

Immutep Limited Class Action Reminder - Robbins LLP Encourages IMMP Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP is Investigating Allegations that Immutep Limited (IMMP) Misled Investors Regarding the Viability and Efficacy of its Drug CandidateOn May 5, 2026, a class action was filed on behalf of all investors who purchased or otherwise acquired Immutep Limited American Depository Receipts (NASDAQ: IMMP) between March 24, 2025 and March 12, 2026. Immutep is an Australian-based biotechnology company focused on developing Lymphocyte Activation Gene-3 (LAG-3) related i...
Back to Newsroom